Aged cells help tumors block the immune system
Tumors have a strategy to keep the immune system out: they surround themselves with senescent cells that block immune access. A new approach targets both problems simultaneously, with promising results in animal models.
Immunotherapy, in which a patient’s own immune system attacks the tumour, works well for some cancers. But for many solid tumours (cancers in organs such as the liver, lung or breast) results have been disappointing. The tumour manages to literally exclude immune cells. One mechanism behind this involves senescent cells: cells that have stopped dividing but are not cleared away, and that release pro-inflammatory signals.
Nanoparticles that hit two targets at once
The study, published in Science, describes a nanotherapy in which small particles (tens of nanometres in size) are directed toward the tumour. These particles are designed to simultaneously target senescent cells in the tumour area and reduce immune exclusion: the barrier that prevents T cells (immune cells capable of killing tumour cells) from entering the tumour. In mouse models with fibrosis and cancer, the treatment led to less scar tissue surrounding the tumour and better T-cell infiltration.
The combination is relevant because fibrosis (excessive scar formation) and senescent cells are two mechanisms that reinforce each other in the tumour microenvironment. By targeting both at once, researchers hope to overcome resistance to existing immunotherapies. Whether this works in humans is not yet known. The study was conducted in mouse models, and the step toward clinical application remains substantial.
Broader relevance for aging and cancer
Senescent cells accumulate as people age. They contribute to chronic inflammation and alter the environment of surrounding tissue. In the context of cancer, this can help tumours grow and evade immune surveillance. This study represents an example of research linking aging biology with oncology, a field that is growing rapidly and may yield new therapeutic strategies in the future.
Search terms to explore further: cellular senescence tumour immunity | immune exclusion cancer therapy | nanotherapy fibrosis tumour microenvironment